Executive summary

Published in the Green Journal, this ESTRO-HERO (Health Economics in Radiation Oncology) analysis reported about 4 millions new cancer patients are predicted in 2025 in Europe, a 15.9% increase compared to the number of 2012, and about 2 millions cancer patients would have an indication for radiotherapy in 2025, a 16.1% increase from year 2012.

New radiotherapy techniques enable delivery precision and less toxic effects combined with new chemotherapy could also influence the number of candidates for radiotherapy treatments. This paper is to raise awareness for resource planning and placing investments to adequately manage demands of cancer patients.

Key content topics